|
Tislelizumab, an anti-PD-1 antibody, in patients with urothelial carcinoma (UC): Results from an ongoing phase I/II study |
|
|
|
Titel: |
Tislelizumab, an anti-PD-1 antibody, in patients with urothelial carcinoma (UC): Results from an ongoing phase I/II study |
Auteur: |
Sandhu, S. Hill, A. Gan, H. Friedlander, M. Voskoboynik, M. Barlow, P. Townsend, A. Song, J. Zhang, Y. Liang, L. Desai, J. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 29 () nr. S10 pagina's x28 |
Jaar: |
2018 |
Inhoud: |
|
Uitgever: |
THE AUTHORS |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|